Browse the evidence

Power output in the closing sprints of exhaustive time trial cycling increased with creatine ingestion.

Creatine supplementation may enhance performance in the final stages of endurance cycling events.

Tai Chi exercise therapy significantly decreases fasting blood glucose (FBG) by an average of 0.79 mmol/L in patients with type 2 diabetes mellitus (T2DM).

Incorporating Tai Chi into exercise prescriptions may help lower blood glucose levels in T2DM patients.

Tai Chi exercise therapy significantly decreases glycated hemoglobin (HbA1c) by an average of 1.10% in patients with T2DM.

Tai Chi may be an effective intervention for improving long-term glucose control in T2DM patients.

In females, egg consumption >50 g/d is associated with a 34% lower risk of central obesity.

Encouraging egg consumption in females may help reduce the risk of central obesity.

Personalized nutrition informed by genetic and metabolic profiling is a promising approach to tailor recovery strategies.

Tailoring recovery nutrition based on individual profiles can enhance recovery outcomes.

Exercise is a key component of nonalcoholic fatty liver disease (NAFLD) treatment.

Practitioners should incorporate exercise into treatment plans for NAFLD.

The effectiveness of exercise in improving NAFLD is influenced by exercise type, intensity, and volume.

Exercise programs should consider these factors to optimize treatment outcomes.

Regular physical activity participation can aid in preventing chronic diseases.

Encouraging regular physical activity is essential for chronic disease prevention.

Tirzepatide exhibited favorable effects on glycemic control, with reductions in HbA1c levels ranging from 20.4 mmol/mol with the 5 mg dose to 28.2 mmol/mol with the 15 mg dose.

Tirzepatide may improve glycemic control in patients with T2DM.

Tirzepatide resulted in mean waist circumference reductions ranging from 4.3 to 9.8 cm across subgroups.

Tirzepatide is effective in reducing waist circumference in East Asian individuals with type 2 diabetes.

Aerobic capacity increased only after HIIT and ENT by +14% ± 7% and +11% ± 11% respectively (P < 0.05).

HIIT and endurance training are effective for improving aerobic capacity in middle-aged men.

Retatrutide and orforglipron are effective in weight loss and improving metabolic parameters associated with obesity.

These drugs may be considered as therapeutic options for obesity management.

Weight reduction and management strategies may improve chronic kidney disease outcomes.

Weight management should be considered as part of CKD treatment plans.

Nutritional strategies are necessary to confront adaptations to body mass loss.

Dietitians should implement specific nutritional strategies to support weight loss efforts.

Nutrient timing is a strategy for enhancing muscular adaptations and athletic performance.

Practitioners should consider nutrient timing as a potential strategy for improving muscle adaptations.

Higher carbohydrate intake was associated with lower CVD risk, with the lowest risk for quintile 3 (41.0%–44.3% energy as carbohydrate) versus quintile 1 (<37.1% energy as carbohydrate) (OR 0.56, 95% CI 0.35 to 0.91, p=0.02).

Practitioners may consider recommending moderate carbohydrate intake for reducing CVD risk in this population.

5-10% weight loss leads to significant improvement in glycemic control, lipids and blood pressure.

Weight loss of 5-10% should be targeted to improve health outcomes in patients with type 2 diabetes.

A weight-centric therapeutic approach is rational to improve glycemic and other metabolic outcomes in patients with T2DM.

Adopting a weight-centric approach can enhance treatment outcomes for T2DM patients.

Resistance-based exercise programs resulted in a significant change of +0.8 kg in lean mass (95% CI = 0.6 to 0.9 kg, P < 0.001).

Resistance training can effectively increase muscle mass in overweight and obese individuals.

Higher intake of dairy can decrease total cholesterol and reduce waist circumference and increase HDL cholesterol.

Encouraging higher dairy consumption may help improve cholesterol levels and waist circumference.

Sustained improvements were noted in body mass (-7.6 %), HbA1c (-0.3 %), triglycerides (-18.4 %), HDL-C (+17.4 %), and inflammatory markers.

Practitioners can expect significant improvements in metabolic health markers with this dietary approach.

Traditional ergo nutritional supplementation of carbohydrates and proteins combined improves recovery processes.

Incorporating carbohydrates and proteins in recovery nutrition is beneficial.

Complete T2DM remission was achieved in 78.3%, 76.2%, and 71.4% at 1, 3, and ≥5 years respectively.

Bariatric surgery can lead to significant long-term remission of type 2 diabetes in obese patients.

Both liraglutide (3 mg) and naltrexone/bupropion (32/360 mg) improved body weight and composition, carbohydrate and lipid metabolism, and liver fat and function.

Practitioners can consider both liraglutide and naltrexone/bupropion as effective options for improving metabolic health in patients with obesity.